Literature DB >> 6287076

Isolation and partial characterization of surface components of cell line MDA-MB-231 derived from a human metastatic breast carcinoma.

E Walker-Nasir, J F Codington, M R Jahnke, T C Fuller, R W Jeanloz.   

Abstract

Neuraminidase (Vibrio cholerae) treatment of human metastatic mammary carcinoma MDA-MB-231 cells grown in culture released 0.60-0.63 mg of N-acetylneuraminic acid from 10(9) cells. Incubation of intact cells with a modified trypsin and fractionation by gel filtration gave mainly O-glycopeptides. The presence of O-glycosyl-linked chains having one or two carbohydrate residues was confirmed by treatment of the glycopeptide fractions with galactose oxidase, followed by reduction with alkaline sodium borotritide and fractionation. The major glycopeptide fraction, which consisted of 53% carbohydrate and 47% protein, and a minor glycopeptide fraction each inhibited hemagglutination by peanut lectin. These results suggest the presence of O-beta-D-galactopyranosyl-(1 leads to 3)-O-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-(1 leads to 3)-L-serine (threonine) residues. The absorptive capacities for anti-HLA-A2 and anti-HLA-B8 antisera were slightly greater for intact than for lyophilized cells, which suggested that masking of these major histocompatibility antigens did not occur in intact cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287076

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

1.  Mutation of the retinoblastoma tumor suppressor gene sensitizes cancers to mitotic inhibitor induced cell death.

Authors:  Jiong Zhao; Zhenyu Zhang; Yang Liao; Wei Du
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

2.  Chemically Programmed Bispecific Antibody Targeting Legumain Protease and αvβ3 Integrin Mediates Strong Antitumor Effects.

Authors:  Yuan Liu; Rajib K Goswami; Cheng Liu; Subhash C Sinha
Journal:  Mol Pharm       Date:  2015-06-09       Impact factor: 4.939

3.  A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells.

Authors:  Qing Ye; Samuel Kantonen; Karen M Henkels; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

4.  Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.

Authors:  James W Antoon; Martin D White; Jennifer L Driver; Matthew E Burow; Barbara S Beckman
Journal:  Exp Biol Med (Maywood)       Date:  2012-08-02

5.  Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.

Authors:  William Weidong Du; Burton B Yang; Bing L Yang; Zhaoqun Deng; Ling Fang; Sze Wan Shan; Zina Jeyapalan; Yaou Zhang; Arun Seth; Albert J Yee
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.